MedTrace Logo

Quadratus Lumborum Block : Effect on Acute Pain and Quality of Recovery After Laparoscopic Renal Surgery

NCT02841982 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2019-05-20

No results posted yet for this study

Summary

This prospective, randomized study,control study aims to compare the analgesic effect,opioids consumption,quality of recovery,length of hospital stay and incidence of chronic pain,et al. between single-injection QLB(quadratus lumborum block)+ intravenous patient-controlled analgesia (IPCA) and intravenous patient-controlled analgesia (IPCA) alone in patients undergoing laparoscopic renal surgeries.

Conditions

  • Laparoscopic Renal Surgery
  • Pain Management
  • Nerve Block

Interventions

PROCEDURE

single-injection QLB(quadratus lumborum block)

Inject local anesthetics in between quadratus lumborum and psoas major without continuous local infusion

DEVICE

Philip CX50 Ultrasound Scanner

The curved (C1-5) probe of Philip CX 50 Ultrasound Scanner is used for scan

DEVICE

PAJUNK StimuLong

DRUG

single dose ropivacaine

* 0.6ml/kg 0.5% ropivacaine with 1:200,000 adrenaline. * given immediately after the correct position of the tip of the needle has been verified.

DRUG

Morphine given as IPCA(intravenous patient controlled analgesia)

bolus: 1.5\~2mg, lock time: 10min, 1h limitation: 6\~8mg

Sponsors & Collaborators

  • Cui Xulei

    lead OTHER

Principal Investigators

  • Yuguang Huang, MD. · Peking Union Medical College Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
17 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-08-31
Primary Completion
2018-11-30
Completion
2018-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02841982 on ClinicalTrials.gov